search
Back to results

Bone Regeneration With Mesenchymal Stem Cells

Primary Purpose

Mandibular Fractures

Status
Completed
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Application of autologous mesenchymal stem cells
Sponsored by
Instituto Mexicano del Seguro Social
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Mandibular Fractures focused on measuring Mesenchymal Stem Cells, Treatment

Eligibility Criteria

17 Years - 59 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Entitled patients to the Mexican Institute of Social Security
  • Patients with mandibular condyle fractures associated or not to other initial fracture that required Open reduction and internal fixation
  • Ages from 17 to 59 years
  • Both female and male gender
  • Patients who gave their consent to be part of this trial

Exclusion Criteria:

  • Patients younger than 17 years and older than 59 years
  • Chronic-degenerative diseases, active smoking, collagen disorders
  • Patients with signs of infection in the aimed area to treat and in whom the fracture occurred in a longer period than 10 days before their surgery.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    Fractures with Mesenchymal Stem Cells

    Fractures without Mesenchymal Stem Cells

    Arm Description

    10 patients with mandibular fractures were managed by open reduction and internal fixation, with application of autologous mesenchymal stem cells on the fracture site.

    10 patients with mandibular fractures were managed by open reduction and internal fixation, without application of autologous mesenchymal stem cells on the fracture site.

    Outcomes

    Primary Outcome Measures

    Change of bone quality
    After the procedure, imaging control by X-ray and analysis by software, was done after surgery at weeks 4 and 12. X- ray units: Voxels. Software analysis by Image Processing and Analysis ImageJ 1.43
    Change of bone quality
    After the procedure, imaging control by CT scan and analysis by software, was done after surgery at weeks 4 and 12. CT scan units: Hounsfiled . Software analysis by Image Processing and Analysis ImageJ 1.43

    Secondary Outcome Measures

    Number of patients with infection ( increase of local temperature, tenderness, leukocyte count >10,000/ µL, confirmed by Gram stain and blood culture).
    Infection suggested by clinical diagnosis increase of leukocyte levels, and confirmed by Gram stain and blood culture of local sample.
    Number of patients with bleeding after surgery (Persistent bleeding, ineffectiveness stopping bleeding using dressings)
    Persistent bleeding after surgery, that did not stop by dressings. If this complication developed, it had to be managed by surgical techniques.
    Number of patients with surgical wound dehiscence (subcutaneous tissue , bone or osteosynthesis material exposed and seen through opened skin )
    Clinical signs of dehiscence on the surgical incision, surgical material or bone seen though the skin. This diagnosis is done by clinical findings. Does not need any laboratory or image test.

    Full Information

    First Posted
    April 20, 2016
    Last Updated
    April 26, 2016
    Sponsor
    Instituto Mexicano del Seguro Social
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02755922
    Brief Title
    Bone Regeneration With Mesenchymal Stem Cells
    Official Title
    Bone Regeneration in Mandibular Fractures After the Application of Autologous Mesenchymal Stem Cells. Randomized Clinical Trial.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2016
    Overall Recruitment Status
    Completed
    Study Start Date
    April 2010 (undefined)
    Primary Completion Date
    September 2010 (Actual)
    Study Completion Date
    December 2010 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Instituto Mexicano del Seguro Social

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Mandible fractures are a common cause of facial injury in adults. The autologous mesenchymal stem cell (AMSC) transplantation, is proposed as an alternative to the conventional graft treatment, improving bone neoformation.The objective was to evaluate the effectiveness of AMSCs application in mandibular fractures to reduce regeneration time and increase bone quality.
    Detailed Description
    Single blinded controlled clinical trial in patients with mandibular angle fracture. The patients were divided into: Study Group (SG): fracture reduction plus application of AMSCs, Control Group (CG): Same procedure without AMSCs. AMSCs were obtained from adipose tissue , 24 hrs before the procedure. Intensity and density were evaluated in normal bone and fractured bone, at 4 and 12 weeks after surgery using panoramic radiography and computed tomography. (CT) A total of 20 patients, 10 in each group were included. SG with a mean age of 31.2 ± 6.3 years and CG 29.7 ± 7.2 years, all patients were male. Bone quality at week 4 SG 108.82 ± 3.4 vs CG 93.92 ± 2.6 (p = 0.000) by panoramic radiography, SG 123 ± 4.53 vs CG 99.72 ± 5.72 (p = 0.000) by CT. At week 12: SG 153.53±1.83 vs CG 101.81±4.83 (p= 0.000) by panoramic radiography, SG 165.4 ± 4.2 vs CG 112.05±2.1 (p= 0.000) by CT. The application of AMSCs presented at week 4 similar ossification values compared with normal bone and a 36.48 % higher ossification rate at week 12.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Mandibular Fractures
    Keywords
    Mesenchymal Stem Cells, Treatment

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 3
    Interventional Study Model
    Parallel Assignment
    Masking
    Outcomes Assessor
    Allocation
    Randomized
    Enrollment
    20 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Fractures with Mesenchymal Stem Cells
    Arm Type
    Experimental
    Arm Description
    10 patients with mandibular fractures were managed by open reduction and internal fixation, with application of autologous mesenchymal stem cells on the fracture site.
    Arm Title
    Fractures without Mesenchymal Stem Cells
    Arm Type
    No Intervention
    Arm Description
    10 patients with mandibular fractures were managed by open reduction and internal fixation, without application of autologous mesenchymal stem cells on the fracture site.
    Intervention Type
    Biological
    Intervention Name(s)
    Application of autologous mesenchymal stem cells
    Intervention Description
    within the surgical procedure, mesenchymal stem cells, were applied on the fracture site. Imaging by X-ray and CT and imaging analysis was done after fracture repair, at week 4 and week 12
    Primary Outcome Measure Information:
    Title
    Change of bone quality
    Description
    After the procedure, imaging control by X-ray and analysis by software, was done after surgery at weeks 4 and 12. X- ray units: Voxels. Software analysis by Image Processing and Analysis ImageJ 1.43
    Time Frame
    from the moment of fracture diagnosis to week 4 and week 12 after surgery
    Title
    Change of bone quality
    Description
    After the procedure, imaging control by CT scan and analysis by software, was done after surgery at weeks 4 and 12. CT scan units: Hounsfiled . Software analysis by Image Processing and Analysis ImageJ 1.43
    Time Frame
    from the moment of fracture diagnosis to week 4 and week 12 after surgery
    Secondary Outcome Measure Information:
    Title
    Number of patients with infection ( increase of local temperature, tenderness, leukocyte count >10,000/ µL, confirmed by Gram stain and blood culture).
    Description
    Infection suggested by clinical diagnosis increase of leukocyte levels, and confirmed by Gram stain and blood culture of local sample.
    Time Frame
    from immediate postoperative period to three months after surgery
    Title
    Number of patients with bleeding after surgery (Persistent bleeding, ineffectiveness stopping bleeding using dressings)
    Description
    Persistent bleeding after surgery, that did not stop by dressings. If this complication developed, it had to be managed by surgical techniques.
    Time Frame
    from immediate postoperative period to 1 week after surgery
    Title
    Number of patients with surgical wound dehiscence (subcutaneous tissue , bone or osteosynthesis material exposed and seen through opened skin )
    Description
    Clinical signs of dehiscence on the surgical incision, surgical material or bone seen though the skin. This diagnosis is done by clinical findings. Does not need any laboratory or image test.
    Time Frame
    from immediate postoperative period to one month

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    17 Years
    Maximum Age & Unit of Time
    59 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Entitled patients to the Mexican Institute of Social Security Patients with mandibular condyle fractures associated or not to other initial fracture that required Open reduction and internal fixation Ages from 17 to 59 years Both female and male gender Patients who gave their consent to be part of this trial Exclusion Criteria: Patients younger than 17 years and older than 59 years Chronic-degenerative diseases, active smoking, collagen disorders Patients with signs of infection in the aimed area to treat and in whom the fracture occurred in a longer period than 10 days before their surgery.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Alejandro Gonzalez Ojeda, M.D., Ph.D.
    Organizational Affiliation
    Instituto Mexicano del Seguro Social
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Yes

    Learn more about this trial

    Bone Regeneration With Mesenchymal Stem Cells

    We'll reach out to this number within 24 hrs